Cansortium Inc. (OTCMKTS:CNTMF) Short Interest Up 991.1% in April

Cansortium Inc. (OTCMKTS:CNTMF) was the target of a large growth in short interest in the month of April. As of April 30th, there was short interest totaling 32,199 shares, a growth of 991.1% from the April 15th total of 2,951 shares. Based on an average daily volume of 1,114,429 shares, the days-to-cover ratio is presently 0.0 days.

Cansortium Trading Up 0.4%

OTCMKTS:CNTMF traded up $0.00 during midday trading on Wednesday, reaching $0.02. 20,946 shares of the company traded hands, compared to its average volume of 430,980. Cansortium has a twelve month low of $0.02 and a twelve month high of $0.09. The company has a fifty day moving average price of $0.03 and a 200 day moving average price of $0.04.

Cansortium (OTCMKTS:CNTMF) last released its quarterly earnings data on Thursday, April 30th. The company reported ($0.16) earnings per share (EPS) for the quarter. During the same quarter last year, the business posted ($0.14) earnings per share.

About Cansortium

Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.